173 related articles for article (PubMed ID: 12410848)
21. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
[TBL] [Abstract][Full Text] [Related]
22. Vasoactive renal factors and the progression of diabetic nephropathy.
Wassef L; Langham RG; Kelly DJ
Curr Pharm Des; 2004; 10(27):3373-84. PubMed ID: 15544522
[TBL] [Abstract][Full Text] [Related]
23. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
24. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D and diabetic nephropathy.
Li YC
Curr Diab Rep; 2008 Dec; 8(6):464-9. PubMed ID: 18990303
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress.
Deng X; Cheng J; Shen M
J Endocrinol Invest; 2016 Jun; 39(6):657-66. PubMed ID: 26691308
[TBL] [Abstract][Full Text] [Related]
27. Role of growth factors in diabetic kidney disease.
Chiarelli F; Gaspari S; Marcovecchio ML
Horm Metab Res; 2009 Aug; 41(8):585-93. PubMed ID: 19452424
[TBL] [Abstract][Full Text] [Related]
28. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of diabetic nephropathy.
Cooper ME; Gilbert RE; Epstein M
Metabolism; 1998 Dec; 47(12 Suppl 1):3-6. PubMed ID: 9867062
[TBL] [Abstract][Full Text] [Related]
30. Role of advanced glycation end products in diabetic nephropathy.
Forbes JM; Cooper ME; Oldfield MD; Thomas MC
J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S254-8. PubMed ID: 12874442
[TBL] [Abstract][Full Text] [Related]
31. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
32. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
Wolf G
Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
[TBL] [Abstract][Full Text] [Related]
33. Activation of a local renin angiotensin system in podocytes by glucose.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy.
Kumar Pasupulati A; Chitra PS; Reddy GB
Biomol Concepts; 2016 Dec; 7(5-6):293-309. PubMed ID: 27816946
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathways in diabetic nephropathy.
Kawanami D; Matoba K; Utsunomiya K
Histol Histopathol; 2016 Oct; 31(10):1059-67. PubMed ID: 27094540
[TBL] [Abstract][Full Text] [Related]
36. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
37. A Reassessment of the Pathophysiology of Progressive Cardiorenal Disorders.
Re RN
Med Clin North Am; 2017 Jan; 101(1):103-115. PubMed ID: 27884222
[TBL] [Abstract][Full Text] [Related]
38. The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy.
Feng Q; Liu D; Lu Y; Liu Z
J Immunol Res; 2020; 2020():6193407. PubMed ID: 32411800
[TBL] [Abstract][Full Text] [Related]
39. Low-protein diet supplemented with ketoacids ameliorates proteinuria in 3/4 nephrectomised rats by directly inhibiting the intrarenal renin-angiotensin system.
Zhang JY; Yin Y; Ni L; Long Q; You L; Zhang Q; Lin SY; Chen J
Br J Nutr; 2016 Nov; 116(9):1491-1501. PubMed ID: 27753426
[TBL] [Abstract][Full Text] [Related]
40. A Glimpse of the Mechanisms Related to Renal Fibrosis in Diabetic Nephropathy.
Zeng LF; Xiao Y; Sun L
Adv Exp Med Biol; 2019; 1165():49-79. PubMed ID: 31399961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
